Stock Analysts’ updated eps estimates for Saturday, January 13th: Intec Pharma (NASDAQ:NTEC) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. Zacks Investment Research currently has $8.00 target price on the stock. According to Zacks, “Intec Pharma Ltd. is a biopharmaceutical company. The company focused on developing drugs […]
